 Millendo Therapeutics Inc NASDAQ: MLND has agreed to merge with privately-held Tempest Therapeutics Inc in an all-stock transaction. The combined company will operate under the Tempest Therapeutics moniker under ticker TPST, focusing on advancing Tempests oncology pipeline of small molecule candidates. 